SocraTec R&D GmbH
22
1
1
21
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 22 trials
100.0%
+13.5% vs industry average
9%
2 trials in Phase 3/4
0%
0 of 21 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (22)
To Evaluate the Adhesion of TK-254RX on Healthy Participants
Role: collaborator
Phase III Trial to Evaluate the Efficacy and Safety in Patients With Ankle Sprains.
Role: collaborator
Phase III Trial to Assess the Safety and Efficacy of TK-254RX in Patients With Contusions
Role: collaborator
Bioavailability of Trazodone Hydrochloride (New Polymer) vs. Trazodone Hydrochloride Contramid® at Steady-state.
Role: collaborator
To Assess the Effect of the Special Condition on the Pharmacokinetics and Tolerability of the Esflurbiprofen Topical System (EFTS) in Healthy Volunteers.
Role: collaborator
To Assess the Bioavailability of TK-254RX in Comparison with Oral Flurbiprofen Tablets and the Adhesion of TK-254RX in Healthy Subjects
Role: collaborator
Clinical Trial to Investigate Patch Adhesion of Rotigotine Containing Patches in Patients With Parkinson's Disease
Role: lead
Open Label Trial to Evaluate the Adhesion of TK-254RX in Healthy Volunteers.
Role: collaborator
Rivastigmine Bioequivalence Trial With Multiple Applications of Transdermal Patches (9.5 mg/24 h)
Role: lead
Rivastigmine Bioequivalence Trial With Multiple Application of Transdermal Patches (13.3mg/24h)
Role: collaborator
Cannabidiol Bioavailability Trial With Oral Multiple Dose Administration
Role: lead
S-flurbiprofen Bioavailability Trial to Compare a Newly Developed Patch vs. a Marketed Tablet
Role: lead
Estriol and Trimegestone Dose-response Trial With Single Dose Application of Vaginal Rings
Role: collaborator
Rivastigmine Bioequivalence Trial With Multiple Application of Transdermal Patches (9.5mg/24h)
Role: lead
Rivastigmine BA Trial With Multiple Application of Transdermal Patches, Adaptation and Tapering Phase
Role: lead
Pharmacokinetics and Pharmacodynamics of 3 Dosages of Estriol After Continuous Vaginal Administration for 21 Days
Role: collaborator
Pharmaco-Scintigraphic Study to Evaluate the Release Profile of Metronidazole Benzoate Capsules
Role: collaborator
Ibuprofen Bioavailability Trial With Oral Single Dose Administration.
Role: lead
Characterisation of Relative Bioavailability With Bioequivalence Assessment of Deferiprone Tablets After Oral Single Dose Administration
Role: lead
Placebo Controlled Study for Characterisation of Immunological Effects and Safety of Active O2
Role: collaborator